-
IntroducedNov 17, 2021
-
Passed House
-
Passed Senate
-
Signed into Law
Insurance Coverages for Drugs and Medical Procedures and Treatments; Prohibits health insurers & HMOs from requiring, before providing prescription drug coverage for treatment of stage 4 metastatic cancer & associated conditions, that treatment have failed with different drug; prohibits insurers & HMOs from excluding coverage for certain drugs on certain grounds; prohibits insurers & HMOs from requiring home infusion for certain cancer treatment drugs or that certain cancer treatment drugs be sent to certain entities for home infusion unless certain condition is met; specifies requirement for prior authorization form; specifies requirements for, & restrictions on, health insurers & pharmacy benefits managers relating to prior authorization information, requirements, restrictions, & changes; specifies timeframes in which prior authorization requests must be authorized or denied & patient & patient's provider must be notified.
Last Action See all actions
House • Mar 14, 2022: Died in Finance & Facilities Subcommittee
Latest Bill Text See all bill texts
Official Summary/Bill Text
Comments on HB 633
Tweets
Whip Lists
Sponsors
- Joseph
Votes
Actions
- Mar 14, 2022 | House
- Died in Finance & Facilities Subcommittee
- Mar 12, 2022 | House
- Indefinitely postponed and withdrawn from consideration
- Jan 11, 2022 | House
- 1st Reading (Original Filed Version)
- Dec 06, 2021 | House
- Referred to Finance & Facilities Subcommittee
- Referred to Appropriations Committee
- Referred to Health & Human Services Committee
- Now in Finance & Facilities Subcommittee
- Nov 17, 2021 | House
- Filed
Bill Texts
Documents